Skip to main content
American Journal of Public Health logoLink to American Journal of Public Health
letter
. 2016 Mar;106(3):569–570. doi: 10.2105/AJPH.2015.303029

Voigt Responds

Kristin Voigt 1,
PMCID: PMC4815964  PMID: 26885963

I concur with Dawson and Maziak’s call for real-world solutions to the challenges posed by e-cigarettes. However, any such solutions should also reflect an appreciation of, and engagement with, the relevant ethical and justice-based concerns. To think through these concerns, we need to untangle several strands of normative argument implicit in the current debate about e-cigarettes. My article focused on one such strand: the concern that e-cigarettes could contribute to the renormalization of conventional cigarettes and thereby undermine progress made in tobacco control. In my article, I argued that renormalization concerns could support the case for restricting the marketing of e-cigarettes, but that they are problematic when it comes to restricting where e-cigarettes can be used.

Although concerns about the renormalization of conventional cigarettes are playing an important role in the debate about how to regulate e-cigarettes, arguments based on these concerns have mostly gone unchallenged; my article considered which conclusions can—and cannot—be drawn from such arguments. It is crucial to these debates that we take into account not only that smokers have become heavily stigmatized,1 but also how closely smoking has come to be associated with several forms of disadvantage, including class and poverty,2 racial and ethnic minority status,3 and poor mental health4 (a recent article in AJPH also emphasizes the high smoking rates among sexual and gender minorities5).

As Dawson and Maziak emphasize, the denormalization of smoking has of course been driven by a range of factors beyond public health policy and regulation, including a better understanding of its risks and harms. However, denormalization is also an explicit goal in many tobacco control strategies and has been endorsed by bodies such as the World Health Organization.6 That many factors outside of public health policy have contributed to negative perceptions of smokers does not relieve policymakers and public health experts of the responsibility to anticipate possible stigmatizing effects of the strategies they advocate and to make a reasoned judgement about whether any such effects are acceptable.

REFERENCES

  • 1.Stuber J, Galea S, Link B. Smoking and the emergence of a stigmatized social status. Soc Sci Med. 2008;67(3):420–430. doi: 10.1016/j.socscimed.2008.03.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Graham H. Smoking, stigma and social class. J Soc Policy. 2012;41(1):83–99. [Google Scholar]
  • 3.Barbeau EM, Krieger N, Soobader M-J. Working class matters: socioeconomic disadvantage, race/ethnicity, gender, and smoking in NHIS 2000. Am J Public Health. 2004;94(2):269–278. doi: 10.2105/ajph.94.2.269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Schroeder SA, Morris CD. Confronting a neglected epidemic: tobacco cessation for persons with mental illnesses and substance abuse problems. Annu Rev Public Health. 2010;31(1):297–314. doi: 10.1146/annurev.publhealth.012809.103701. [DOI] [PubMed] [Google Scholar]
  • 5.Antin TMJ, Antin T, Lipperman-Kreda S, Hunt G. Tobacco denormalization as a public health strategy: implications for sexual and gender minorities. Am J Public Health. 2015;105(12):2426–2429. doi: 10.2105/AJPH.2015.302806. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Voigt K. “If you smoke, you stink.” Denormalisation strategies for the improvement of health-related behaviours: the case of tobacco. In: Strech D, Hirschberg I, Marckmann G, editors. Ethics in Public Health and Health Policy. Amsterdam, The Netherlands: Springer Netherlands; 2013. pp. 47–61. [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES